Glucocorticoids: Mechanisms of action and anti-inflammatory potential in asthma

Mediators of Inflammation

Volumn 7, Issue 4, 1998, Pages 229-237

  Van Der Velden, V H J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Asthma; Bronchial epithelial cells; Glucocorticoids; Inflammation

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; ENDOTHELIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHITIS; BRONCHUS MUCOSA; DNA SEQUENCE; DRUG MECHANISM; DRUG RECEPTOR BINDING; HORMONE RESPONSIVE ELEMENT; HUMAN; LUNG FUNCTION; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TARGET CELL; TRANSCRIPTION REGULATION;

ANIMALS; ASTHMA; CYTOKINES; GLUCOCORTICOIDS; HUMANS; LUNG; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTION, GENETIC;

EID: 0031656612     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629359890910     Document Type: Review

References (173)

1. Carryer HM, Koelsche GA, Prickman LE, Maytum CK, Lake CF, Williams HL. Effects of cortisone on bronchial asthma and hay fever occuring in subjects sensitive to ragweed pollen. Proc Staff Meet, Mayo Clin 1950; 25: 482-486.
2. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993; 148: S1-S26.
3. Hollenberg SM, Weinberger C, Ong ES, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985; 318: 635-641.
4. Hollenberg SM, Giguere V, Segui P, Evans RM. Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 1987; 49: 39-46.
5. Kumar V, Green S, Staub A, Chambon P. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 1986; 5: 2231-2236.
6. Rusconi S, Yamamoto KR. Functional dissection of the hormone and DNA binding activities of the glucocorticoid receptor. EMBO J 1987; 6: 1309-1315.
7. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889-895.
8. Evans RM, Hollenberg SM. Cooperative and positional independent trans-activation domains of the human glucocorticoid receptor. Cold Spring Harb Symp Quant Biol 1988; 53: 813-818.
9. Picard D, Yamamoto KR. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J 1987; 6: 3333-3340.
10. Kumar V, Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 1988; 55: 145-156.
11. Freedman LP, Luisi BF, Korszun ZR, Basavappa R, Sigler PB, Yamamoto KR. The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature 1988; 334: 543-546.
12. Freedman LP. Anatomy of the steroid receptor zinc finger region. Endocr Rev 1992; 13: 129-145.
13. Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler PB. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 1991; 352: 497-505.
14. Schena M, Freedman LP, Yamamoto KR. Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. Genes Dev 1989; 3: 1590-1601.
15. de Waal RM. The anti-inflammatory activity of glucocorticoids. Mol Biol Rep 1994; 19: 81-88.
16. Encio IJ, Detera-Wadleigh SD. The genomic structure of the human glucocorticoid receptor. J Biol Chem 1991; 266: 7182-7188.
17. Otto C, Reichardt HM, Schutz G. Absence of glucocorticoid receptor-beta in mice. J Biol Chem 1997; 272: 26665-26668.
18. Hecht K, Carlstedt-Duke J, Stierna P, Gustafsson J, Bronnegard M, Wikstrom AC. Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant represser. J Biol Chem 1997; 272: 26659-26664.
19. Oakley RH, Webster JC, Sar M, Parker CR, Jr, Cidlowski JA. Expression and subcellular distribution of the beta-isoform of the human glucocorticoid receptor. Endocrinology 1997; 138: 5028-5038.
20. Burnstein KL, Cidlowski JA. The down side of glucocorticoid receptor regulation. Mol Cell Endocrinol 1992; 83: C1-C8.
21. Bronnegard M. Steroid receptor number. Individual variation and downregulation by treatment. Am J Respir Crit Care Med 1996; 154: S28-S32.
22. Rosewicz S, McDonald AR, Maddux BA, Goldfine ID, Miesfeld RL, Logsdon CD. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem 1988; 263: 2581-2584.
23. Korn SH, Wouters EF, Wesseling G, Arends JW, Thunnissen FB. In vitro and in vivo modulation of alpha- and beta-glucocorticoid-receptor mRNA in human bronchial epithelium. Am J Respir Crit Care Med 1997; 155: 1117-1122.
24. Kam JC, Szefler SJ, Surs W, Sher ER, Leung DY. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 1993; 151: 3460-3466.
25. Rakasz E, Gal A, Biro J, Balas G, Falus A. Modulation of glucocorticosteroid binding in human lymphoid, monocytoid and hepatoma cell lines by inflammatory cytokines interleukin (IL)-1 beta, IL-6 and tumour necrosis factor (TNF)-alpha. Scand J Immunol 1993; 37: 684-689.
26. Salkowski CA, Vogel SN. Lipopolysaccharide increases glucocorticoid receptor expression in murine macrophages. A possible mechanism for glucocorticoid-mediated suppression of endotoxicity. J Immunol 1992; 149: 4041-4047.
27. Salkowski CA, Vogel SN. IFN-gamma mediates increased glucocorticoid receptor expression in murine macrophages. J Immunol 1992; 148: 2770-2777.
28. Verheggen MM, van Hal PT, Adriaansen-Soeting PW, et al. Modulation of glucocorticoid receptor expression in human bronchial epithelial cell lines by IL-1 beta, TNF-alpha and LPS. Eur Respir J 1996; 9: 2036-2043.
29. Adcock IM, Gilbey T, Gelder CM, Chung KF, Barnes PJ. Glucocorticoid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med 1996; 154: 771-782.
30. Gustafsson JA, Carlstedt-Duke J, Poellinger L, et al. Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocr Rev 1987; 8: 185-234.
31. Mendel DB, Orti E. Isoform composition and stoichiometry of the approximately 90-kDa heat shock protein associated with glucocorticoid receptors. J Biol Chem 1988; 263: 6695-6702.
32. Smith DF, Stensgard BA, Welch WJ, Toft DO. Assembly of progesterone receptor with heat shock proteins and receptor activation are ATP mediated events. J Biol Chem 1992; 267: 1350-1356.
33. Sanchez ER. Hsp56: a novel heat shock protein associated with untransformed steroid receptor complexes. J Biol Chem 1990; 265: 22067-22070.
34. Lebeau MC, Massol N, Herrick J, et al. P59, an hsp 90-binding protein, Cloning and sequencing of its cDNA and prepration of a peptide-directed polyclonal antibody. J Biol Chem 1992; 267: 4281-4284.
35. Truss M, Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 1993; 14: 459-479.
36. Beato M. Gene regulation by steroid hormones. Cell 1989; 56: 335-344.
37. Schule R, Rangarajan P, Kliewer S, et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 1990; 62: 1217-1226.
38. Strahle U, Schmid W, Schutz G. Synergistic action of the glucocorticoid receptor with transcription factors. EMBO J 1988; 7: 3389-3395.
39. Didonato JA, Saatcioglu F, Karin M. Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids. Am J Respir Crit Care Med 1996; 154: S11-S15.
40. Parker M. Enhancer elements activated by steroid hormones? Nature 1983; 304: 687-688.
41. Becker P, Renkawitz R, Schutz G. Tissue-specific DNaseI hypersensitive sites in the 5′-flanking sequences of the tryptophan oxygenase and the tyrosine aminotransferase genes. EMBO J 1984; 3: 2015-2020.
42. Fritton HP, Igo-Kemenes T, Nowock J, Strech-Jurk U, Theisen M, Sippel AE. Alternative sets of DNase I-hypersensitive sites characterize the various functional states of the chicken lysozyme gene. Nature 1984; 311: 163-165.
43. Zaret KS, Yamamoto KR. Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element. Cell 1984; 38: 29-38.
44. Perlmann T, Wrange O. Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome. EMBO J 1988; 7: 3073-3079.
45. Barnes PJ. Molecular mechanisms of steroid action in asthma. J Allergy Clin Immunol 1996; 97: 159-168.
46. Ransone LJ, Verma IM. Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol 1990; 6: 539-557.
47. Angel P, Karin M. The role of Jun, Fos and the AP-I complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072: 129-157.
48. Jonat C, Rahmsdorf HJ, Park KK, et al. Antitumor promotion and antiinflammation: down-modulation of AP-I (Fos/Jun) activity by glucocorticoid hormone. Cell 1990; 62: 1189-1204.
49. Yang-Yen HF, Chambard JC, Sun YL, et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990; 62: 1205-1215.
50. Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. [Review]. Cell 1989; 58: 227-229.
51. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994; 91: 752-756.
52. Grilli M, Chiu JJ, Lenardo MJ. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993; 143: 1-62.
53. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994; 10: 405-455.
54. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270: 286-290.
55. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283-286.
56. Haskill S, Beg AA, Tompkins SM, et al. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell 1991; 65: 1281-1289.
57. Finco TS, Baldwin AS. Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity 1995; 3: 263-372.
58. Mukaida N, Morita M, Ishikawa Y, et al. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 1994; 269: 13289-13295.
59. Caldenhoven E, Liden J, Wissink S, et al. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 1995; 9: 401-412.
60. Yamamoto KK, Gonzalez GA, Menzel P, Rivier J, Montminy MR. Characterization of a bipartite activator domain in transcription factor CREB. Cell 1990; 60: 611-617.
61. Adcock IM, Stevens DA, Barnes PJ. Interactions of glucocorticoids and beta 2-agonists. Eur Respir J 1996; 9: 160-168.
62. Adcock IM, Peters MJ, Brown CR, Stevens DA, Barnes PJ. High concentrations of beta-adrenergic agonists inhibit DNA binding of glucocorticoids in human lung in vitro. Biochem Soc Trans 1995; 23: 217S.
63. Peters MJ, Adcock IM, Brown CR, Barnes PJ. Beta-adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharmacol 1995; 289: 275-281.
64. Peppel K, Vinci JM, Baglioni C. The AU-rich sequences in the 3′ untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J Exp Med 1991; 173: 349-355.
65. Lee SW, Tsou AP, Chan H, et al. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA Proc Natl Acad Sci USA 1988; 85: 1204-1208.
66. Schwiebert LM, Stellato C, Schleimer RP. The epithelium as a target of glucocorticoid action in the treatment of asthma. Am J Respir Crit Care Med 1996; 154: S16-S19.
67. LeVan TD, Behr FD, Adkins KK, Miesfeld RL, Bloom JW. Glucocorticoid receptor signaling in a bronchial epithelial cell line. Am J Physiol 1997; 272: L838-L843.
68. Cox G, Ohtoshi T, Vancheri C, et al. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol 1991; 4: 525-531.
69. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992; 89: 1001-1009.
70. Berkman N, Robichaud A, Krishnan VL, et al. Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10 and -13. Immunology 1996; 87: 599-603.
71. Stellato C, Beck LA, Gorgone GA, et al. Expression of the chemokine RANTES by a human bronchial epithelial cell line Modulation by cytokines and glucocorticoids. J Immunol 1995; 155: 410-418.
72. Kwon OJ, Au BT, Collins PD, et al. Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells. Immunology 1994; 81: 389-394.
73. Lilly CM, Nakamura H, Kesselman H, et al. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest 1997; 99: 1767-1773.
74. Bedard M, McClure CD, Schiller NL, Francoeur C, Cantin A, Denis M. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells implications for cystic fibrosis. Am J Respir Cell Mol Biol 1993; 9: 455-462.
75. Kwon OJ, Jose PJ, Robbins RA, Schall TJ, Williams TJ, Barnes PJ. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol 1995; 12: 488-496.
76. Levine SJ, Larivee P, Logun C, Angus CW, Shelhamer JH. Corticosteroids differentially regulate secretion of IL-6, IL-8, and G-CSF by a human bronchial epithelial cell line. Am J Physiol 1993; 265: L360-L368.
77. Sousa AR, Poston RN, Lane SJ, Nakhosteen JA, Lee TH. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am Rev Respir Dis 1993; 147: 1557-1561.
78. Sousa AR, Trigg CJ, Lane SJ, et al. Effect of inhaled glucocorticoids on IL-1 beta and IL-1 receptor antagonist (IL-1 ra) expression in asthmatic bronchial epithelium. Thorax 1997; 52: 407-410.
79. Trigg CJ, Manolitsas ND, Wang J, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994; 150: 17-22.
80. Wang JH, Devalia JL, Xia C, Sapsford RJ, Davies RJ. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol 1996; 14: 27-35.
81. Bai TR, Zhou D, Weir T, et al. Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am J Physiol 1995; 269: L309-L317.
82. Adcock IM, Peters M, Gelder C, Shirasaki H, Brown CR, Barnes PJ. Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. J Mol Endocrinol 1993; 11: 1-7.
83. Mak JC, Nishikawa M, Shirasaki H, Miyayasu K, Barnes PJ. Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo. J Clin Invest 1995; 96: 99-106.
84. Tan S, Hall IP, Dewar J, Dow E, Lipworth B. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 1997; 350: 995-999.
85. Colotta F, Re F, Muzio M, et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993; 261: 472-475.
86. Dower SK, Fanslow W, Jacobs C, Waugh S, Sims JE, Widmer MB. Interleukin-1 antagonists. Ther Immunol 1994; 1: 113-122.
87. Re F, Muzio M, De Rossi M, et al. The type II 'receptor' as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med 1994; 179: 739-743.
88. Levine SJ, Logun C, Chopra DP, Rhim JS, Shelhamer JH. Protein kinase C, interleukin-1 beta, and corticosteroids regulate shedding of the type I, 55 kDa TNF receptor from human airway epithelial cells. Am J Respir Cell Mol Biol 1996; 14: 254-261.
89. Geisterfer M, Richards C, Baumann M, Fey G, Gywnne D, Gauldie J. Regulation of IL-6 and the hepatic IL-6 receptor in acute inflammation in vivo. Cytokine 1993; 5: 1-7.
90. Snyers L, De Wit L, Content J. Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells. Proc Natl Acad Sci USA 1990; 87: 2838-2842.
91. Takizawa H, Ohtoshi T, Yamashita N, Oka T, Ito K. Interleukin 6-receptor expression on human bronchial epithelial cells: regulation by IL-1 and IL-6. Am J Physiol 1996; 270: L346-L352.
92. Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA 1995; 92: 7809-7813.
93. Robbins RA, Barnes PJ, Springall DR, et al. Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun 1994; 203: 209-218.
94. Berkman N, Robichaud A, Robbins RA, et al. Inhibition of inducible nitric oxide synthase expression by interleukin-4 and interleukin-13 in human lung epithelial cells. Immunology 1996; 89: 363-367.
95. Adcock IM, Brown CR, Kwon O, Barnes PJ. Oxidative stress induces NF kappa B DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 1994; 199: 1518-1524.
96. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Clin 1994; 269: 4705-4708.
97. Barnes PJ. Nitric oxide and asthma. Res Immunol 1995; 146: 698-702.
98. Schalkwijk C, Vervoordeldonk M, Pfeilschifter J, Marki F, van den Bosch H. Cytokine- and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone. Biochem Biophys Res Commun 1991; 180: 46-52.
99. Mitchell JA, Belvisi MG, Akarasereenont P, et al. Induction of cyclooxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol 1994; 113: 1008-1014.
100. van der Velden VHJ, Naber BAE, Van der Spoel P, Hoogsteden MC, Versnel MA. Cytokines and glucocorticoids modulate human bronchial epithelial cell peptidases. Cytokine 1998; 10: 55-65.
101. Lang Z, Murlas CG. Dexamethasone increases airway epithelial cell neutral endopeptidase by enhancing transcription and new protein synthesis. Lung 1993; 171: 161-172.
102. Borson DB, Gruenert DC. Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. Am J Physiol 1991; 260: L83-L89.
103. Nadel JA, Borson DB. Modulation of neurogenic inflammation by neutral endopeptidase. Am Rev Respir Dis 1991; 143: S33-S36.
104. Sont JK, van Krieken JH, van Klink HC, et al. Enhanced expression of neutral endopeptidase (NEP) in airway epithelium in biopsies from steroid- versus nonsteroid-treated patients with atopic asthma. Am J Respir Cell Mol Biol 1997; 16: 549-556.
105. Gandhi CK, Berkowitz DE, Watkins WD. Endothelins. Biochemistry and pathophysiologic actions. Anesthesiology 1994; 80: 892-905.
106. Vittori E, Marini M, Fasoli A, De Franchis R, Mattoli S. Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids. Am Rev Respir Dis 1992; 146: 1320-1325.
107. Hay DW, Hubbard WC, Undem BJ. Endothelin-induced contraction and mediator release in human bronchus. Br J Pharmacol 1993; 110: 392-398.
108. Mattoli S, Mezzetti M, Riva G, Allegra L, Fasoli A. Specific binding of endothelin on human bronchial smooth muscle cells in culture and secretion of endothelin-like material from bronchial epithelial cells. Am J Respir Cell Mol Biol 1990; 3: 145-151.
109. Barnes PJ. Endothelins and pulmonary diseases. J Appl Physiol 1994; 77: 1051-1059.
110. Mansoor AM, Honda M, Saida K, et al. Endothelin induced collagen remodeling in experimental pulmonary hypertension. Biochem Biophys Res Commun 1995; 215: 981-986.
111. Rizvi MA, Katwa L. Spadone DP, Myers PR. The effects of endothelin-1 on collagen type I and type III synthesis in cultured porcine coronary artery vascular smooth muscle cells. J Mol Cell Biol 1996; 28: 243-252.
112. Dawes KE, Cambrey AD, Campa JS, et al. Changes in collagen metabolism in response to endothelin-1: evidence for fibroblast heterogeneity. Int J Biochem Cell Biol 1996; 28: 229-238.
113. Springall DR, Howarth PH, Counihan H, Djukanovic R, Holgate ST, Polak JM. Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet 1991; 337: 697-701.
114. Redington AE, Springall DR, Meng QH, et al. Immunoreactive endothelin in bronchial biopsy specimens: increased expression in asthma and modulation by corticosteroid therapy. J Allergy Clin Immunol 1997; 100: 544-552.
115. Redington AE, Springall DR, Meng QH, et al. Immunoreactive endothelin in bronchial biopsy specimens increased expression in asthma and modulation by corticosteroid therapy. J Allergy Clin Immunol 1997; 100: 544-552.
116. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocurticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1992; 89: 9991-9995.
117. van de Stolpe A, Caldenhoven E, Raaijmakers JA, van der Saag PT, Koenderman L. Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am J Respir Cell Mol Biol 1993; 8: 340-347.
118. Paolieri F, Battifora M, Riccio AM, et al. Inhibition of adhesion molecules by budesonide on a human epithelial cell line (lung carcinoma). Allergy 1997; 52: 935-943.
119. Montefort S, Herbert CA, Robinson C, Holgate ST. The bronchial epithelium as a target for inflammatory attack in asthma. [Review]. Clin Exp Allergy 1992; 22: 511-520.
120. Sato M, Takizawa H, Kohyama T, et al. Eosinophil adhesion to human bronchial epithelial cells: regulation by cytokines. Int Arch Allergy Immunol 1997; 113: 203-205.
121. Goulding NJ, Guyre PM. Regulation of inflammation by lipocortin 1. Immunol Today 1992; 13: 295-297.
122. Geisow MJ, Walker JH, Boustead C, Taylor W. Annexins-new family of Ca2+-regulated-phospholipid binding protein. Biosci Rep 1987; 7: 289-298.
123. Flower RJ. Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol 1988; 94: 987-1015.
124. Wallner BP, Mattaliano RJ, Hession C, et al. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential antiinflammatory activity. Nature 1986; 320: 77-81.
125. Verheggen MM, De Bont HI. Adriaansen-Soeting PWC, et al. Expression of lipocortins in human bronchial epithelial cells: effects of IL-1B, TNF-a, LPS and dexamethasone. Med Inflam 1996; 5: 210-217.
126. van Hal PT, Overbeek SE, Hoogsteden HC, et al. Eicosanoids and lipocortin-1 in BAL fluid in asthma: effects of smoking and inhaled g glucocorticoids. J Appl Physiol 1996; 81: 548-555.
127. Levine SJ, Benfield T, Shelhamer JH. Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line. Am J Respir Cell Mol Biol 1996; 15: 245-251.
128. Abbinante-Nissen JM, Simpson LG, Leikauf GD. Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol 1995; 268: L601-L606.
129. Djukanovic R, Homeyard S, Gratziou C, et al. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Am J Respir Crit Care Med 1997; 155: 826-832.
130. Naseer T, Minshall EM, Leung DY, et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997; 155: 845-851.
131. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993; 92: 313-324.
132. Bentley AM, Hamid Q, Robinson DS, et al. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 1996; 153: 551-556.
133. Djukanovic R, Wilson JW, Britten KM, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992; 145: 669-674.
134. Booth H, Richmond I, Ward C, Gardiner PV, Harkawat R, Walters EH. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med 1995; 152: 45-52.
135. Olivieri D, Chetta A, Del Donno M, et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997; 155: 1864-1871.
136. Duddridge M, Ward C, Hendrick DJ, Walters EH. Changes in bronchoalveolar lavage inflammatory cells in asthmatic patients treated with high dose inhaled beclomethasone dipropionate. Eur Respir J 1993; 6: 489-497.
137. Schleimer RP, Schulman EN, MacGlashan DW Jr, et al. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest 1983; 71: 1830-1835.
138. Schleimer RP. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis 1990; 141: S59-S69.
139. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988; 334: 395-402.
140. Inaba K, Steinman RM. Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release. J Exp Med 1984; 160: 1717-1735.
141. Möller GM, Overbeek SE, van Helden-Meeuwsen CG, et al. Increased number of dendritic cells in the bronchial mucosa of atopic asthmatics: downregulation by inhaled corticosteroids. Clin Exp Allergy 1996; 26: 517-524.
142. Bousquet J, Chanez P, Lacoste JY, et al. eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
143. Wardlaw AJ, Kay AB. The role of the eosinophil in the pathogenesis of asthma. Allergy 1987; 42: 321-335.
144. Djukanovic R, Wilson JW, Britten KM, et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990; 142: 863-871.
145. Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434-457.
146. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142: 1407-1413.
147. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139: 806-817.
148. Adelroth E, Rosenhall L, Johansson SA, Linden M, Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis 1990; 142: 91-99.
149. Lopez AF, Williamson DJ, Gamble JR, et al. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 1986; 78: 1220-1228.
150. Owen WF, Rothenberg ME, Petersen J, et al. Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 1989; 170: 343-348.
151. Rothenberg ME, Owen WF Jr, Silberstein DS, et al. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest 1988; 81: 1986-1992.
152. Clutterbuck EJ, Hirst EM, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood 1989; 73: 1504-1512.
153. Nakamura Y, Azuma M, Okano Y, et al. Upregulatory effects of interleukin-4 and interleukin-13 but not interleukin-10 on granulocyte/ macrophage colony-stimulating factor production by human bronchial epithelial cells. Am J Respir Cell Mol Biol 1996; 15: 680-687.
154. Robinson DS, Assoufi B, Durham SR, Kay AB. Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment. Clin Exp Allergy 1995; 25: 1118-1127.
155. Laitinen IA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992; 90; 32-42.
156. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155: 542-548.
157. Burke C, Power CK, Norris A, Condez A, Schmekel B, Poulter LW. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur Respir J 1992; 5: 73-79.
158. Krouwels FH, van der Heijden JF, Lutter R, van Neerven RJ, Jansen HM, Out TA. Glucocorticosteroids affect functions of airway- and blood-derived human T-cell clones, favoring the Th1 profile through two mechanisms. Am J Respir Cell Mol Biol 1996; 14: 388-397.
159. Lundgren R. Scanning electron microscopic studies of bronchial mucosa before and during treatment with beclomethasone dipropionate inhalations. Scand J Respir Dis Suppl 1977; 101: 179-187.
160. Lundgren JD, Hirata F, Marom Z, et al. Dexamethasone inhibits respiratory glycoconjugate secretion from feline airways in vitro by the induction of lipocortin (lipomodulin) synthesis. Am Rev Respir Dis 1988; 137: 353-357.
161. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 1992; 145: 890-899.
162. Schleimer RP. An overview of glucocorticoid anti-inflammatory actions Eur J Clin Pharmacol 1993; 45: S3-S7.
163. van de Graaf EA, Out TA, Roos CM, Jansen HM. Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Effects of therapy with inhaled steroids. Am Rev Respir Dis 1991; 143: 362-368.
164. Erjefalt I, Persson CG. Anti-asthma drugs attenuate inflammatory-leakage of plasma into airway lumen. Acta Physiol Scand 1986; 128: 653-654.
165. Boschetto P, Rogers DF, Fabbri LM, Barnes PJ. Corticosteroid inhibition of airway microvascular leakage. Am Rev Respir Dis 1991; 143: 605-609.
166. Shimura S, Sasaki T, Ikeda K, Yamauchi K, Sasaki H, Takishima T. Direct inhibitory action of glucocorticoid on glycoconjugate secretion from airway submucosal glands. Am Rev Respir Dis 1990; 141: 1044-1049.
167. Osterman K, Carlholm M, Ekelund J, et al. Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics. Eur Respir J 1997; 10: 2210-2215.
168. Simons FE. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med 1997; 337: 1659-1665.
169. Barnes PJ. Effect of corticosteroids on airway hyperresponsiveness. Am Rev Respir Dis 1990; 141: S70-S76.
170. Cockcroft DW, Murdock KY. comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 1987; 79: 734-740.
171. Dahl R, Johansson SA. Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction. Eur J Respir Dis Suppl 1982; 122: 167-175.
172. Burge PS. The effects of corticosteroids on the immediate asthmatic reaction. Eur J Respir Dis Suppl 1982; 122: 163-166.
173. Martin GL, Atkins PC, Dunsky EH, Zweiman B. Effects of theophylline, terbutaline, and prednisone on antigen-induced bronchospasm and mediator release. J Allergy Clin Immunol 1980; 66: 204-212.